The effect of ipragliflozin on ectopic fat accumulation in non-obese type 2 diabetic patients with increased visceral fat
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000019071
- Lead Sponsor
- Tokyo Medical and Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Not provided
Patients who are taking SGLT2 inhibitors Patients with insulin treatment Patients with severe diabetic retinopathy Patients who are hypersensitive to SGLT2 inhibitors Patients with cogestive heart failure (NYHA classification class III or IV) Patients with active infection, malignancy, severe liver or renal diseases Patients who had recently received operation or had severe trauma Patients who had experienced atherothrombotic events including myocardila infarction and/or stroke Patients with severe ketosis or diabetic coma/pre-coma Patients who are unable to figure out the consent due to dementia or impairment of consciousness Pregnant women, lactating woman, women who are planning to get pregnant Patients who were judged inadequate to enroll in the study by medical doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of epicaridial fat volume from baseline at 12 weeks
- Secondary Outcome Measures
Name Time Method